Cannabinoids: a novel treatment for glaucoma

Acta Ophthalmologica

“…cannabinoids are emerging novel agents for the treatment of glaucoma.

Although increased intraocular pressure (IOP) is a risk factor, associated retinal damage is of prime concern. This study determines the ability of cannabinoids to decrease IOP and confer neuroprotection…

Conclusion:┬áTopically applied cannabinoids are effective agents that reduce IOP and confer neuroprotection and are prime candidates for potential glaucoma treatment.”

Facebook Twitter Pinterest Stumbleupon Tumblr Posterous

Leave a Reply

Your email address will not be published. Required fields are marked *